Rheumatology Doctors in Mcallen, TX Accepting Medicare

3 Rheumatology doctors found. Showing 1 - 3

Dr. Encarnacion Rodriguez, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 4300 N Mccoll Rd, Mcallen, TX 78504 Phone: 956-630-1170

Dr. Brian Jay Glazer, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 110 E Savannah Ave, Bldg B Suite 202, Mcallen, TX 78503 Phone: 956-686-7611    Fax: 956-618-3164

Mr. Elvin R. Garcia, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 811 E Fern Ave Ste 1, Mcallen, TX 78501 Phone: 956-630-2114    Fax: 956-630-2155

News Archive

Researchers develop new 3D bone marrow culture systems

Stromal cells, as distinct from hematopoietic cells, are an essential component of the bone marrow microenvironment and are necessary for the long-term maintenance of hematopoietic stem cells (HSCs) in vitro.

NCCC physicians use new gene sequencing equipment for testing abnormal DNA in cancerous tumor cells

Clinical laboratory experts and physicians at Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC) achieved 100 percent accuracy in testing for abnormal DNA in cancerous tumor cells with its new gene sequencing equipment and panels.

Emory team identifies conditions that make memory T cells slip away during chronic infections

After recovering from the flu or another acute infection, your immune system is ready to react quickly if you run into the same virus again. White blood cells called memory T cells develop during the infection and help the immune system remember the virus and attack it if it comes back.

Babies weaned on junk food: Study

According to a recent study in Perth, Australia, babies here are being fed high calorie junk foods like biscuits, cakes, hot chips and ice cream before they turn one. This practice affects their eating habits for life say researchers. The report appeared in the Australian Journal of Nutrition and Dietetics. The study was undertaken by the Telethon Institute of Child Health Research, University of Western Australia and Curtin University and South Australia's Flinders University.

NWBT accelerates addition of clinical sites for new enrollment into ongoing GBM brain cancer trial

Northwest Biotherapeutics today announced that it has accelerated the addition of clinical trial sites, exceeding its projections for the doubling of such sites across the U.S. this calendar quarter, for enrollment of new patients into the Company's ongoing 240-patient randomized, double blind, placebo controlled clinical trial of DCVax immune therapy for Glioblastoma multiforme, the most lethal form of brain cancer.

Read more Medical News

› Verified 8 days ago